These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 877065)
101. Domiciliary drug therapy of pulmonary tuberculosis in a rural population in India. Frimodt-Möller J Tubercle; 1968 Mar; 49():Suppl:22-3. PubMed ID: 5659242 [No Abstract] [Full Text] [Related]
103. [Preliminary note on the use of parenteral rifampicin (slow venous infusion). Blood levels and tolerance]. Giura R; Scardaccione M; Roccamo B; Giura C G Ital Chemioter; 1978; 25(1):45-8. PubMed ID: 751848 [No Abstract] [Full Text] [Related]
104. [Rifampicin in dermatological therapy. Preliminary note]. Gandola M; Peverelli G Minerva Dermatol; 1968 Oct; 43(10):524-8. PubMed ID: 5718231 [No Abstract] [Full Text] [Related]
105. [New findings in the biotransformation and pharmacokinetics of antitubercular agents]. Ritter W Prax Pneumol; 1973 Mar; 27(3):139-45. PubMed ID: 4121631 [No Abstract] [Full Text] [Related]
107. [Separation, determination and pharmacokinestics of rifampicin and its biotransformation products]. Winsel K; Iwainsky H; Werner E; Eule H Pharmazie; 1976; 31(2):95-9. PubMed ID: 8786 [No Abstract] [Full Text] [Related]
108. Serologic studies on the occurrence of specific rifampicin antibodies during continuous rifampicin treatment--its frequency and significance. Kropp R; Krüpe M; Jungbluth H Pneumonologie; 1976 Apr; 153(2):109-17. PubMed ID: 1264830 [No Abstract] [Full Text] [Related]
109. [Biotransformation of rifampicin in pulmonary tuberculosis patients]. Ioffe RA Antibiotiki; 1977; 22(2):177-80. PubMed ID: 558736 [TBL] [Abstract][Full Text] [Related]
110. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration. Iwainsky H; Winsel K; Werner E; Eule H Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983 [No Abstract] [Full Text] [Related]
111. [Delayed results of treatment of pulmonary tuberculosis with rifampicin]. Fréour P; Bernadou M; Chomy P Gruzlica; 1974 May; 42(5):439-42. PubMed ID: 4464235 [No Abstract] [Full Text] [Related]
112. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid]. Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194 [No Abstract] [Full Text] [Related]
113. [Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis]. Gol'dshteĭn VD; Ioffe RA; Kriukov VL Probl Tuberk; 1977 Apr; (4):61-6. PubMed ID: 877065 [No Abstract] [Full Text] [Related]
114. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects. Eule H; Werner E; Winsel K; Iwainsky H Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295 [No Abstract] [Full Text] [Related]